Bupropion and cognitive-behavioral treatment for depression in smoking cessation

Nicotine and Tobacco Research

Volumn 9, Issue 7, 2007, Pages 721-730

  Brown, Richard A ^a   Niaura, Raymond ^a   Lloyd Richardson, Elizabeth E ^b   Strong, David R ^a   Kahler, Christopher W ^c   Abrantes, Ana M ^a   Abrams, David ^d   Miller, Ivan W ^a  

^a BUTLER HOSPITAL   (United States)

^b MIRIAM HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; PLACEBO;

ADULT; ANXIETY; ARTICLE; BEHAVIOR THERAPY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COGNITIVE THERAPY; CONCENTRATION LOSS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK FACTOR; SELF REPORT; SIDE EFFECT; SMOKING CESSATION; STOMACH DISCOMFORT; SYMPTOM; THORAX PAIN; TOBACCO DEPENDENCE; TONGUE SWELLING; TREATMENT DURATION; VALIDATION PROCESS;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOTHERAPY, GROUP; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 34347337567     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1080/14622200701416955     Document Type: Article

References (57)

1. Ahluwalia, J. S., Harris, K. J., Catley, D., Okuyemi, K. S. and Mayo, M. S. (2002) Sustained-release bupropion for smoking cessation in African Americans: A randomized controlled trial. The Journal of the American Medical Association, 288, pp. 468-474.
2. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, Author, Washington, DC
3. Anda, R. F., Williamson, D. F., Escobedo, L. G., Mast, E. E., Giovino, G. A. and Remington, P. L. (1990) Depression and the dynamics of smoking: A national perspective. The Journal of the American Medical Association, 264, pp. 1541-1545.
4. Brown, R. A., Kahler, C. W., Niaura, R., Abrams, D. B., Sales, S. D., Ramsey, S. E., Goldstein, M. G., Burgess, E. S. and Miller, I. W. (2001) Cognitive-behavioral treatment for depression in smoking cessation. Journal of Consulting and Clinical Psychology, 69, pp. 471-480.
5. Cinciripini, P. M., Wetter, D. W., Fouladi, R. T., Blalock, J. A., Carter, B. L., Cinciripini, L. G. and Baile, W. F. (2003) The effects of depressed mood on smoking cessation: Mediation by postcessation self-efficacy. Journal of Consulting and Clinical Psychology, 71, pp. 292-301.
6. Cohen, J. (1988) Statistical power for the behavioral sciences, Lawrence-Erlbaum Associates, Hillsdale, NJ
7. Conte, H. R., Plutchik, R., Wild, K. V. and Karasu, T. B. (1986) Combined psychotherapy and pharmacotherapy for depression. A systematic analysis of the evidence. Archives of General Psychiatry, 43, pp. 471-479.
8. Covey, L. (1999) Tobacco cessation among patients with depression. Primary Care, 26, pp. 691-706.
9. Covey, L. (2004) Comments on "History of depression and smoking cessation outcome: A meta-analysis." Nicotine & Tobacco Research, 6, pp. 743-745.
10. Cox, L. S., Patten, C. A., Niaura, R. S., Decker, P. A., Rigotti, N., Sachs, D. P., Buist, A. S. and Hurt, R. D. (2004) Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression. Journal of General Internal Medicine, 19, pp. 828-834.
11. Cummings, S. R. and Richard, R. J. (1988) Optimum cutoff points for biochemical validation of smoking status. American Journal of Public Health, 78, pp. 574-575.
12. Dalsgaro, O. J., Hansen, N. C., Soes-Petersen, U., Evald, T., Hoegholm, A., Barber, J. and Vestbo, J. (2004) A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees. Nicotine & Tobacco Research, 6, pp. 55-61.
13. DeRubeis, R. J., Hollon, S. D., Amsterdam, J. D., Shelton, R. C., Young, P. R., Salomon, R. M., O'Reardon, J. P., Lovett, M. L., Gladis, M. M., Brown, L. L. and Gallop, R. (2005) Cognitive therapy vs medications in the treatment of moderate to severe depression. Archives of General Psychiatry, 62, pp. 409-416.
14. Evins, A. E., Mays, V. K., Rigotti, N. A., Tisdale, T., Cather, C. and Goff, D. C. (2001) A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine & Tobacco Research, 3, pp. 397-403.
15. Fiore, M. C., Bailey, W. C., Cohen, S. J., Dorfman, S. F., Goldstein, M. G., Gritz, E. R., Heyman, R. B., Holbrook, J., Jaen, C. R., Kottke, T. E., Lando, H. A., Mecklenbur, R., Mullen, P. D., Nett, L. M., Robinson, L., Stitzer, M., Tommasello, A. C., Villejo, L. and Wewers, M. E. (2000) Treating tobacco use and dependence. Clinical practice guideline, Rockville, MD; U.S. Department of Health and Human Services. Public Health Service.
16. First, M. B., Spitzer, R. L., Gibbon, M. and Williams, J. B. W. (1995) Structured Clinical Interview for DSM-IV Axis I disorders, New York: New York State Psychiatric Institute.
17. Friedman, M., Detweiler-Bedell, J., Leventhal, H., Home, R., Keitner, G. and Miller, I. (2004) Combined psychotherapy and pharmacotherapy for the treatment of major depressive disorder. Clinical Psychology: Science and Practice, 11, pp. 47-68.
18. Friedman, M., Detweiler-Bedell, J., Leventhal, H., Home, R., Keitner, G. and Miller, I. W. (2004) Combined psychotherapy and pharmacotherapy for the treatment of major depressive disorder. Clinical Psychology: Science and Practice, 11, pp. 47-68.
19. George, T. P., Vessicchio, J. C., Termine, A., Bregartner, T. A., Feingold, A., Rounsaville, B. J. and Kosten, T. R. (2002) A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biological Psychiatry, 52, pp. 53-61.
20. Ginsberg, D., Hall, S. M., Reus, V. I. and Muñoz, R. F. (1995) Mood and depression diagnosis in smoking cessation. Experimental and Clinical Psychopharmacology, 3, pp. 389-395.
21. Glassman, A. H. (1993) Cigarette smoking: Implications for psychiatric illness. American Journal of Psychiatry, 150, pp. 546-553.
22. Gonzales, D. H., Nides, M. A., Ferry, L. H., Kustra, R. P., Jamerson, B. D., Segall, N., Herrero, L. A., Krishen, A., Sweeney, A., Buaron, K. and Metz, A. (2001) Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: A randomized placebo-controlled study. Clinical Pharmacology and Therapeutics, 69, pp. 438-444.
23. Grant, B. F., Hasin, D. S., Chou, S. P., Stinson, F. S. and Dawson, D. A. (2004) Nicotine dependence and psychiatric disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61, pp. 1107-1115.
24. Haas, A. L., Muñoz, R. F., Humfleet, G. L., Reus, V. I. and Hall, S. M. (2004) Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. Journal of Consulting and Clinical Psychology, 72, pp. 563-570.
25. Hall, S. M. (2004) The Covey-Hitsman exchange. Nicotine & Tobacco Research, 6, pp. 751-752.
26. Hall, S. M., Humfleet, G. L., Reus, V. I., Muñoz, R. F., Hartz, D. T. and Maude-Griffin, R. (2002) Psychological intervention and antidepressant treatment in smoking cessation. Archives of General Psychiatry, 59, pp. 930-936.
27. Hall, S. M., Muñoz, R. F. and Reus, V. I. (1994) Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. Journal of Consulting and Clinical Psychology, 62, pp. 141-146.
28. Hall, S. M., Muñoz, R. F., Reus, V. I., Sees, K. L., Duncan, C., Humfleet, G. L. and Hartz, D. T. (1996) Mood management and nicotine gum in smoking treatment: A therapeutic contact and placebo-controlled study. Journal of Consulting and Clinical Psychology, 64, pp. 1003-1009.
29. Hall, S. M., Reus, V. I., Muñoz, R. F., Sees, K. L., Humfleet, G., Hartz, D. T., Frederick, S. and Triffleman, E. (1998) Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Archives of General Psychiatry, 55, pp. 683-690.
30. Hayford, K. E., Patten, C. A., Rummans, T. A., Schroeder, D. R., Offord, K. P., Croghan, I. T., Glover, E. D., Sachs, D. P. L. and Hurt, R. D. (1999) Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. British Journal of Psychiatry, 174, pp. 173-178.
31. Hays, J. T. and Ebbert, J. O. (2003) Bupropion for the treatment of tobacco dependence: Guidelines for balancing risks and benefits. CNS Drugs, 17, pp. 71-83.
32. Hays, J. T., Hurt, R. D., Rigotti, N. A., Niaura, R., Gonzales, D., Durcan, M. J., Sachs, D. P., Wolter, T. D., Buist, A. S., Johnston, J. A. and White, J. D. (2001) Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. A randomized, controlled trial. Annals of Internal Medicine, 135, pp. 423-433.
33. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C. and Fagerström, K. O. (1991) The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction, 86, pp. 1119-1127.
34. Hertzberg, M. A., Moore, S. D., Feldman, M. E. and Beckham, J. C. (2001) A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder. Journal of Clinical Psychopharmacology, 21, pp. 94-98.
35. Hitsman, B., Borrelli, B., McChargue, D. E., Spring, B. and Niaura, R. (2003) History of depression and smoking cessation outcome: A meta-analysis. Journal of Consulting and Clinical Psychology, 71, pp. 657-663.
36. Hollon, S. D., DeRubeis, R. J., Evans, M. D., Wiemer, M. J., Garvey, M. J., Grove, W. M. and Tuason, V. B. (1992) Cognitive therapy and pharmacotherapy for depression. Singly and in combination. Archives of General Psychiatry, 49, pp. 774-781.
37. Hollon, S. D., Jarrett, R. B., Nierenberg, A. A., Thase, M. E., Trivedi, M. and Rush, A. J. (2005) Psychotherapy and medication in the treatment of adult and geriatric depression: Which monotherapy or combined treatment?. Journal of Clinical Psychiatry, 66, pp. 455-468.
38. Hurt, R. D., Sachs, D. P. L., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., Khayrallah, M. A., Shroeder, D. R., Glover, P. N., Sullivan, R., Croghan, I. T. and Sullivan, P. M. (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. The New England Journal of Medicine, 337, pp. 1195-1202.
39. Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., Fiore, M. C. and Baker, T. B. (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. The New England Journal of Medicine, 340, pp. 685-691.
40. Keller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., Markowitz, J. C., Nemeroff, C. B., Russell, J. M., Thase, M. E., Trivedi, M. H. and Zajecka, J. (2000) A comparison of nefazodone, the cognitive behavioral analysis system of psychotherapy, and their combination for the treatment of chronic depression. The New England Journal of Medicine, 342, pp. 1462-1470.
41. Killen, J. D., Fortmann, S. P., Kraemer, H. C., Varady, A. N., Davis, L. and Newman, B. (1996) Interactive effects of depression symptoms, nicotine dependence, and weight change on late smoking relapse. Journal of Consulting and Clinical Psychology, 64, pp. 1060-1067.
42. Kinnunen, T., Doherty, K., Militello, F. S. and Garvey, A. J. (1996) Depression and smoking cessation: Characteristics of depressed smokers and effects of nicotine dependence. Journal of Consulting and Clinical Psychology, 64, pp. 791-798.
43. Liang, K. -Y. and Zeger, S. L. (1986) Longitudinal data analysis using generalized linear models. Biometrika, 73, pp. 13-22.
44. Miller, I. W., Keitner, G. I., Ryan, C. E., Solomon, D. A., Cardemil, E. V. and Beevers, C. G. (2005) Treatment matching in the post-hospital care of depressed inpatients. American Journal of Psychiatry, 162, pp. 2131-2138.
45. Niaura, R., Britt, D. M., Shadel, W. G., Goldstein, M., Abrams, D. and Brown, R. (2001) Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychology of Addictive Behaviors, 15, pp. 13-17.
46. Patten, C. A., Martin, J. E., Myers, M. G., Calfas, K. J. and Williams, C. D. (1998) Effectiveness of cognitive-behavioral therapy for smokers with histories of alcohol dependence and depression. Journal of Studies on Alcohol, 59, pp. 327-335.
47. Radloff, L. S. (1977) The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, pp. 385-401.
48. Saxon, A. J., Baer, J. S., Davis, T. M., Sloan, K. L., Malte, C. A., Fitzgibbons, K. and Kivlahan, D. R. (2003) Smoking cessation treatment among dually diagnosed individuals: Preliminary evaluation of different pharmacotherapies. Nicotine & Tobacco Research, 5, pp. 589-596.
49. Simon, J. A., Duncan, C., Carmody, T. P. and Hudes, E. S. (2004) Bupropion for smoking cessation: A randomized trial. Archives of Internal Medicine, 164, pp. 1797-1803.
50. Smith, S. S., Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Jamerson, B., Fiore, M. C. and Baker, T. B. (2003) Targeting smokers at increased risk for relapse: Treating women and those with a history of depression. Nicotine & Tobacco Research, 5, pp. 99-109.
51. SRNT Subcommittee on Biochemical Verification Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research, pp. 149-159.
52. Tonnesen, P., Tonstad, S., Hjalmarson, A., Lebargy, F., Van, I. Spiegel P., Hider, A., Sweet, R. and Townsend, J. (2003) A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation. Journal of Internal Medicine, 254, pp. 184-192.
53. Tonstad, S., Farsang, C., Klaene, G., Lewis, K., Manolis, A., Perruchoud, A. P., Silagy, C., van, I. Spiegel P., Astbury, C., Hider, A. and Sweet, R. (2003) Bupropion SR for smoking cessation in smokers with cardiovascular disease: A multicentre, randomised study. European Heart Journal, 24, pp. 946-955.
54. Upadhyaya, H. P., Brady, K. T. and Wang, W. (2004) Bupropion SR in adolescents with comorbid ADHD and nicotine dependence: A pilot study. Journal of the American Academy of Child and Adolescent Psychiatry, 43, pp. 199-205.
55. Wei, I. (1978) Application of an urn model to the design of sequential controlled clinical trials. Journal of the American Statistical Association, 73, pp. 559-563.
56. Wells, K. B., Stewart, A., Hays, R. D., Burnam, M. A., Rogers, W., Daniels, M., Berry, S., Greenfield, S. and Ware, J. (1989) The functioning and well-being of depressed patients: Results from the Medical Outcomes Study. The Journal of the American Medical Association, 262, pp. 914-919.
57. Zeger, S. L. and Liang, K. -Y. (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics, 42, pp. 121-130.